BeStock  
Stocks › Medical Devices › NVCR

Novocure NVCR

US equityMarket cap rank #3014Medical Devices
$10.71 +$0.02 (+0.19%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $10.71 0.00%
Open$10.61
Prev close$10.69
Day range$10.61 – $11.06
Volume1.64M
Market cap$1.25B
P/E (TTM)–
Dividend yield–

NVCR Stock News

Headlines matching Novocure or the NVCR ticker, most recent first.

  • H.C. Wainwright Maintains Novocure(NVCR.US) With Buy Rating, Raises Target Price to $52 PositiveMarket news · 24 Jul 2026 · Direct mention
  • Wedbush Maintains Novocure(NVCR.US) With Hold Rating, Raises Target Price to $20 PositiveMarket news · 24 Jul 2026 · Direct mention
  • H.C. Wainwright Maintains Novocure(NVCR.US) With Buy Rating, Maintains Target Price $52Market news · 24 Jul 2026 · Direct mention
  • J.P. Morgan Sticks to Its Hold Rating for NovoCure (NVCR)TipRanks · 13 Jul 2026 · Direct mention
  • H.C. Wainwright Maintains Novocure(NVCR.US) With Buy Rating, Maintains Target Price $46Market news · 13 Jul 2026 · Direct mention
  • J.P. Morgan Maintains Novocure(NVCR.US) With Hold Rating, Cuts Target Price to $17 NegativeMarket news · 13 Jul 2026 · Direct mention
  • H.C. Wainwright Maintains Novocure(NVCR.US) With Buy Rating, Cuts Target Price to $46 NegativeMarket news · 18 Jun 2026 · Direct mention
  • Wells Fargo Maintains Novocure(NVCR.US) With Hold Rating, Raises Target Price to $17 PositiveMarket news · 4 May 2026 · Direct mention
  • Piper Sandler Maintains Novocure(NVCR.US) With Buy Rating, Maintains Target Price $27Market news · 26 May 2026 · Direct mention
  • Evercore Maintains Novocure(NVCR.US) With Buy Rating, Raises Target Price to $20 PositiveMarket news · 1 May 2026 · Direct mention
  • H.C. Wainwright Maintains Novocure(NVCR.US) With Buy Rating, Maintains Target Price $48Market news · 1 May 2026 · Direct mention
  • H.C. Wainwright Maintains Novocure(NVCR.US) With Buy Rating, Cuts Target Price to $48 NegativeMarket news · 1 May 2026 · Direct mention
  • Evercore Maintains Novocure(NVCR.US) With Buy Rating, Cuts Target Price to $16 NegativeMarket news · 6 Apr 2026 · Direct mention
  • H.C. Wainwright Keeps Their Buy Rating on NovoCure (NVCR)TipRanks · 21 Apr 2026 · Direct mention
  • H.C. Wainwright Maintains Novocure(NVCR.US) With Buy Rating, Maintains Target Price $49Market news · 21 Apr 2026 · Direct mention

Discussion

No comments yet — be the first to weigh in on NVCR.

Sign in to join the discussion.

Scroll to Top